Respiratory management of the infant with type 1 spinal muscular atrophy

A Bush1, J Fraser, E Jardine

  • 1Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK. a.bush@rbh.nthames.nhs.uk

Insights

This paper discusses respiratory management for infants with spinal muscular atrophy type 1 (SMA-1). It presents a personal approach to this challenging issue, acknowledging polarized views on treatment intensity.

Area of Science:

  • Pediatric Pulmonology
  • Neuromuscular Disorders
  • Neonatal Care

Background:

  • Infants with spinal muscular atrophy type 1 (SMA-1) present complex respiratory challenges.
  • Current clinical approaches to respiratory support in SMA-1 are highly variable and often polarized.
  • There is a need for a structured approach to managing respiratory care in these infants.

Purpose of the Study:

  • To offer a personal perspective and a potential management template for respiratory care in infants with SMA-1.
  • To address the polarized viewpoints on the extent of respiratory support for SMA-1 patients.
  • To provide a framework for decision-making in a complex and emotionally charged area of pediatric care.

Main Methods:

  • This paper presents a personal view and proposed management strategy.
  • It synthesizes current polarized opinions on respiratory support for SMA-1.
  • The focus is specifically on respiratory management, excluding non-respiratory holistic care aspects.

Main Results:

  • The paper highlights the dichotomy in current management strategies for SMA-1 respiratory issues.
  • It acknowledges the extreme ends of the spectrum, from no intervention to long-term invasive ventilation.
  • A template for managing this complex problem is proposed.

Conclusions:

  • A structured, personalized approach is crucial for managing respiratory care in infants with SMA-1.
  • The proposed template aims to guide clinicians through the polarized landscape of treatment options.
  • Effective respiratory management is a key component of holistic care for SMA-1 infants.

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned under...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: